Leishmania donovani: An in vitro study of antimony-resistant amphotericin B-sensitive isolates

Experimental Parasitology

Volumn 114, Issue 4, 2006, Pages 247-252

  Sharief, Abdalla Hassan ^a   Gasim Khalil, Eltahir Awad ^b   Theander, Thor G ^c   Kharazmi, Arsalan ^c   Omer, Samia Ali ^a   Ibrahim, Muntasir Eltayeb ^b  

^a TROPICAL MEDICINE RESEARCH INSTITUTE   (Sudan)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antimony resistant; DAT; direct agglutination test; FCS; fetal calf serum; In vitro sensitivity; Leishmania donovani; parasite survival index; phorbol myristate acetate; PMA; PSI; Sodium stibogluconate; SSG; Sudan; visceral leishmaniasis; VL

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIMONY; STIBOGLUCONATE SODIUM;

AMASTIGOTE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; EVALUATION; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PARASITE ISOLATION; PRIORITY JOURNAL; PROMASTIGOTE; SCREENING TEST; SUDAN; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; BONE MARROW; CELL LINE; DRUG RESISTANCE; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LYMPH NODES; MACROPHAGES; MICE; PARASITIC SENSITIVITY TESTS; SUDAN;

LEISHMANIA DONOVANI; MURINAE;

EID: 33750286677     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2006.03.016     Document Type: Article

References (19)

1. Croft S.L. Monitoring drug resistance in leishmaniasis. Tropical Medicine and International Health 6 (2001) 899-999
2. Davidson R.N., Di Martino L., Gradonli L., et al. Liposomal Amphotericin B (AmBidome) in Mediterranean visceral leishmaniasis: a multi-center trial. Quarterly Journal of Medicine 87 (1994) 75-81
3. El-On J., Sulitzeanu A., and Schnur L.F. Leishmania major: resistance of promastigotes to promomycin and susceptibility of amastigotes to promomycinmethylbenzetholnium chloride ointment. Annals of Tropical Medicine and Parasitology 5 (1991) 323-328
4. Gebre-Hiwot A., Tadesse G., Croft S.L., and Frommel D. An in vitro model for screening antileishmanial drugs: the human leukemia monocyte cell line, THP-1. Acta Tropica 51 (1992) 237-245
5. Harith A.E., Kolk A.H.J., Kager P.A., Leeuwenburg J., Faber F.J., Muigai R., Kiugu S., and Laarman J.J. A simple and economical direct agglutination test for sero-diagnosis and sero-epidemiological studies of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 24 (1986) 364-367
6. Harms G., Zwingen Gregor K., Sandkamp B., Omena S., Pedrosa C., Richter J., Rosenkainmer H., and Feldmeier H. Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferongamma and pentavalent antimony. Journal of Interferon Research 13 (1993) 39-41
7. Herwaldt B.L., and Berman J.D. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. American Journal of Tropical Medicine and Hygiene 46 (1992) 296-306
8. Ibrahim M.E., Hag Ali M., El-Hassan A.M., Theander T.G., and Kharazmi A. Leishmania resistant to sodium stibogluconate: drug-associated macrophage-dependent killing. Parasitology Research 80 (1994) 569-574
9. Khalil E.A.G., El-Hassan A.M., Zijlstra E.E., Hashim F.A., Ibrahim M.E., Ghalib H.W., and Ali M.S. Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond. Annals of Tropical Medicine and Parasitology 92 (1998) 151-158
10. Khalil E.A.G., Hashim F.A., Mustafa M.D., Kordofani A., Satti M., El Hag I.A., El-Safi S.H., Hag Ali M., Zijlstra E.E., El-Hassan A.M., Ghalib H.W., and Ali M.S. A comparative study comparing liposomal Amphotericin B (AmBisome) and sodium stibogluconate in the treatment of kala-azar in the Sudan. East African Medical. Journal 75 (1998) 37-45
11. Kirk R., and Satti M. Observations on the use of sodium stibogluconate in the treatment of kala-azar. Annals of Tropical Medicine and Parasitology 41 (1947) 14-21
12. Mishra M., Biswas U.K., Jha A.M., and Khan A.B. Amphotericin versus stibogluconate in first-line treatment of Indian kala-azar. Lancet ii (1994) 1599-1600
13. Murray H.W., Hariprashad J., and Fichtel R.E. Treatment of experimental visceral leishmaniasis in a T-cell-deficient host: response to Amphotericin B and Pentamidine. Antimicrobial Agents and Chemotherapy 37 (1993) 1504-1505
14. Murray H.W., and Delph-Etienne S. Role of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis. Infection and Immunity 68 (2000) 288-293
15. Sereno D., and Lemersre J.L. Axenically cultured amastigotes forms as an in vitro model for investigation of antiLeishmanial agents. Antimicrobial Agents and Chemotherapy 41 5 (1997) 972-976
16. Sereno D., Cavaleyra M., Zemzoumi K., Maquaire S., Ouaissi A., and Lemesre J.L. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrobial Agents and Chemotherapy 42 (1998) 3097-3102
17. Tsuchiya S., Kobayashi Y., Goto Y., Okumara H., Nakal S., Konno T., and Tada K. Induction of maturation in cultured human monocytic leukemia cells by Phorbol diester. Cancer Research 42 (1982) 1530-1536
18. Ullman B. Multidrug resistance and P-glycoproteins in parasitic protozoa. Journal of Bioenergetics and Biomembranes 27 (1995) 77-84
19. Zijlstra E.E., Siddig M.A., El Hassan A.M., Hofland C., El-Toum I.A., Satti M., and Ghalib H.W. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomised trial of three dosage regimens. Transactions of Royal Society of Tropical Medicine and Hygiene 87 (1993) 307-309